The Enterprise Value as of September 2024 (TTM) for Cue Biopharma, Inc. (CUE) is 8.98M

According to Cue Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.98M. This represents a change of -86.05% compared to the average of 64.33M of the last 4 quarters.

Cue Biopharma, Inc. (CUE) Historical Enterprise Value (quarterly & annually)

How has CUE Enterprise Value performed in the past?

The mean historical Enterprise Value of Cue Biopharma, Inc. over the last ten years is 196.67M. The current 8.98M Enterprise Value has changed 356.37% with respect to the historical average. Over the past ten years (40 quarters), CUE's Enterprise Value was at its highest in in the June 2020 quarter at 640.39M. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Cue Biopharma, Inc. (CUE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cue Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cue Biopharma, Inc. (CUE) Average Enterprise Value

How has CUE Enterprise Value performed in the past?

The current Enterprise Value of Cue Biopharma, Inc. (CUE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cue Biopharma, Inc. (CUE) Enterprise Value vs. Peers

How is CUE’s Enterprise Value compared to its peers?

Cue Biopharma, Inc.’s Enterprise Value is less than Coya Therapeutics, Inc. (58.71M), less than Lantern Pharma Inc. (28.42M), less than Fennec Pharmaceuticals Inc. (128.73M), less than Eliem Therapeutics, Inc. (329.54M), less than Anixa Biosciences, Inc. (107.13M), less than INmune Bio, Inc. (79.80M), less than IN8bio, Inc. (10.13M), less than PolyPid Ltd. (31.37M), less than X4 Pharmaceuticals, Inc. (51.07M), greater than Galera Therapeutics, Inc. (-5796499.00), less than Terns Pharmaceuticals, Inc. (574.47M), less than Day One Biopharmaceuticals, Inc. (966.84M), less than HOOKIPA Pharma Inc. (94.99M), greater than Cognition Therapeutics, Inc. (-4627870.00), greater than TFF Pharmaceuticals, Inc. (3.55M), less than TScan Therapeutics, Inc. (157.75M), greater than Dermata Therapeutics, Inc. (-2182882.00),

Build a custom stock screener for Cue Biopharma, Inc. (CUE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cue Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cue Biopharma, Inc. (CUE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cue Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.